| Name |
|---|
CMD1K Genecardiomyopathy, dilated 1K (autosomal dominant) |
CMD1H Genecardiomyopathy, dilated 1H (autosomal dominant) |
CMD1F Genecardiomyopathy, dilated 1F (autosomal dominant) |
CMD1B Genecardiomyopathy, dilated 1B (autosomal dominant) |
CMD1Q Genecardiomyopathy, dilated 1Q (autosomal dominant) |
SNORC Genesecondary ossification center associated regulator of chondrocyte maturation Predicted to be involved in cartilage development. Predicted to be located in several cellular components, including collagen-containing extracellular matrix; cytoplasm; and extracellular region. Predicted to be active in cell periphery. [provided by Alliance of Genome Resources, Mar 2025] |
AOMS1 GeneAbdominal obesity-metabolic syndrome QTL1 |
AOMS2 Geneabdominal obesity-metabolic syndrome QTL2 |
ASMER1 Geneadipocyte associated metabolic related lncRNA 1 |
CMR1A Genecardiomyopathy, restrictive 1A (autosomal dominant) |
RCM2 Genecardiomyopathy, familial restrictive, 2 |
CMR2A Genecardiomyopathy, restrictive 2A (autosomal recessive) |
CMYA5 Genecardiomyopathy associated 5 Predicted to enable identical protein binding activity and protein phosphatase inhibitor activity. Predicted to act upstream of or within negative regulation of calcineurin-NFAT signaling cascade and regulation of skeletal muscle adaptation. Located in cytosol; nuclear speck; and plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
CMR3A Genecardiomyopathy, restrictive 3A (X-linked) |
CMH21 GeneCardiomyopathy, familial hypertrophic, 21 |